Validation of a strategy to diagnose coronary artery disease and predict cardiac events in high-risk renal transplant candidates

Coronary Artery Disease

Volumn 21, Issue 3, 2010, Pages 164-167

  De Lima, Jose Jayme Galvao ^a   Wolff Gowdak, Luis Henrique ^a   De Paula, Flavio Jota ^a   Ianhez, Luis Estevan ^a   Franchini Ramires, Jose Antonio ^a   Krieger, Eduardo M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coronary angiography; Coronary artery disease; Myocardial scan

Indexed keywords

DIPYRIDAMOLE;

ADULT; ALGORITHM; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DEATH; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HAZARD RATIO; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART STRESS; HUMAN; KIDNEY GRAFT; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS;

ALGORITHMS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HEALTH STATUS INDICATORS; HEART DISEASES; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77951296050     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328332ee5e     Document Type: Article

References (18)

1. Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol 2005; 16:808-816.
2. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57:307-313.
3. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates comparing with noninvasive testing. Hypertension 2003; 42:263-268.
4. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003; 14:431-439.
5. Hase H, Joki N, Ishikawa H, Fukuda H, Imamura Y, Saijyo T, et al. Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of hemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 2004; 19:1161-1167.
6. World Medical Association-Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/e/ policy/b3.htm. [Accessed 31 January 2008]
7. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, et al. American Society of Transplantation. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant 2001; 1 (Suppl 2): 3-95.
8. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol 2006; 47:2130-2139.
9. Boudreau RJ, Strony JT, du Cret RP, Kuni CC, Wag Y, Wilson RF, et al. Perfusion thallium imaging of type 1 diabetes with end-stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology 1990; 175:103-105.
10. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Co RT, Swift C, Braun WE. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990; 49:100-103.
11. Schmidt A, Stefenelli T, Schuster E, Mayer G. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 2001; 37:56-63.
12. Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003; 92:146-151.
13. Caglar M, Mahmoudian B, Aytemir K, Kahraman S, Arici M, Kabakci G, et al. Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nucl Med Commun 2006; 27:61-69.
14. Mistry BM, Bastani B, Solomon H, Hoff J, Aridje DL, Lindsey LM, et al. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Transplant 1998; 12:130-135. (Pubitemid 128721314)
15. Gowdak LHW, de Paula FJ, Meneghetti JC, Cé sar LAM, Krieger EM, Ramires JAF, et al. Cardiac scintigraphy as a predictor tool of cardiovascular events in patients with end-stage renal disease-not so useful in patients with diabetes (abstract). World Congress of Cardiology 2006, Barcelona. Eur Heart J 2006; 27:523.
16. De Lemos JA, Hills LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 1996; 2044-2054.
17. Goldsmith DJA, Covic A. Coronary artery disease in uremia: etiology, diagnosis, and therapy. Kidney Int 2001; 60:2059-2078.
18. Gowdak LHW, de Paula F, Cé sar LAM, Martinez-Filho EE, Ianhez LE, Krieger EM, et al. Screening for significant coronary artery disease in high-risk renal transplant candidates. Coron Artery Dis 2007; 18:553-558.